PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.

• Hanna Trubkina,
• Ihar Iskrou,
• Iryna Lendzina,
• Tatiana Lebedeva,
• Viktirya Smolnikova

Affiliations

Hanna Trubkina

1 State Institution “Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology”, hematology department №3, Minsk, Belarus

Ihar Iskrou

2 State Educational Institution “Belarusian Medical Academy of Postgraduate Education”, Minsk, Belarus

Iryna Lendzina

3 State Institution “Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology”, hematology department №3, Минск, Belarus

Tatiana Lebedeva

4 State Institution “Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology”, Clinical Diagnostic Laboratory STKM, Minsk, Belarus

Viktirya Smolnikova

4 State Institution “Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology”, Clinical Diagnostic Laboratory STKM, Minsk, Belarus